U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07234630) titled 'Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy' on Nov. 14.
Brief Summary: The aim of this research is to measure fibrinolytic activity in neoplastic pathologies in order to provide preliminary data on which to base a future, larger-scale study to determine predictive markers of complication in order to improve patient management.
Primary purpose: measure plasminogen concentration on day 1 in subjects diagnosed with malignant hematological disease, solid tumors, or septic shock, with coagulopathy.
Secondary purpose:
* Estimate the difference in plasminogen concentration at D1 in patients with ...